+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity



Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity



Journal of Clinical Endocrinology and Metabolism 79(6): 1824-1830



To evaluate whether the production of insulin-like growth factor-binding proteins (IGFBPs) is altered in various pathological states due to modification of the hormonal milieu, we analyzed patterns of IGFBPs released into conditioned medium during 48-h serum-free culture of early passages of human skin fibroblasts from control subjects and patients with metabolic disorders. IGFBP-2, -3, -4, and -5 were identified in the conditioned medium by immunoblotting or RIA. Compared with those in eight control subjects by ligand blot analysis, the levels of IGFBP-3, -2, and -5 were reduced to 43%, 47%, and 53% in 10 noninsulin-dependent diabetic patients, respectively, whereas the levels of IGFBP-3 and -2 were reduced to 36% and 23%, respectively, in 3 nondiabetic obese patients with impaired glucose tolerance. In 2 insulin-dependent diabetic patients, the level of IGFBP-3 was reduced by 25% and 40%, respectively, and IGFBP-2 was not detectable. In contrast, a similar level of IGFBP-4 was detected in both normal and patient's conditioned media, except in 1 insulin-dependent diabetic patient. These data indicate that fibroblasts derived from patients with metabolic disorders retain their intrinsic characteristics even after they are removed from their in vivo hormonal milieu.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008298174

Download citation: RISBibTeXText

PMID: 7527414

DOI: 10.1210/jcem.79.6.7527414


Related references

Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity (vol 79, pg 1824, 1994). Journal of Clinical Endocrinology and Metabolism 92(2): 623, 2007

Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 80(2): 393-399, 1995

Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin. Annals of Nutrition & Metabolism 34(6): 333-342, 1990

The clinical importance of insulin resistance in patients with insulin dependent diabetes mellitus and noninsulin dependent diabetes mellitus. Acta Endocrinologica Supplementum 106(263), 1984

Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion. Diabetes Research and Clinical Practice 25(1): 1-12, 1994

Defective insulin action in fibroblasts from noninsulin-dependent diabetes mellitus patients with Gln1152 insulin receptor mutation. Journal of Clinical Endocrinology and Metabolism 77(2): 409-412, 1993

Insulin-like growth factor binding proteins (IGFBPs) in serum and urine and IGFBP-2 protease activity in patients with insulin-dependent diabetes mellitus. Metabolism Clinical and Experimental 49(5): 626-633, 2000

Increased circulating leptin concentrations in insulin-resistant first-degree relatives of patients with non-insulin-dependent diabetes mellitus: relationship to body composition and insulin sensitivity but not to family history of non-insulin-dependent diabetes mellitus. European Journal of Endocrinology 136(2): 173-179, 1997

Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 80(4): 1369-1375, 1995

Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus. Annals of the New York Academy of Sciences 958: 232-234, 2002

Regulation of insulin-like growth factor-binding proteins in rats with insulin-dependent diabetes mellitus. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 210(3): 234-241, 1995

Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus. European Journal of Endocrinology 133(4): 440-444, 1995

Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. Journal of Clinical Endocrinology and Metabolism 78(4): 960-967, 1994

Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. Journal of Clinical Investigation 98(12): 2887-2893, 1996

The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus. Journal of Endocrinology 142(2): 367-374, 1994